KCNH1-related disorders
group of genetic disorders
KCNH1-related disorders are caused by gain-of-function mutations in the gene KCNH1. KCNH1-related disorders are classified as a neurodevelopmental disorder and are characterized by intellectual disability, seizures, and developmental delay. Severity of symptoms are on a wide spectrum, and many individuals also have low muscle tone as babies, distinctive facial features, nail abnormalities, hair overgrowth, and gum overgrowth. The majority of individuals with KCNH1-related disorders have a non-familial (de novo) mutation in the voltage-gated potassium channel subfamily H member 1 (KCNH1) gene that causes the voltage-gated potassium ion channel KCNH1 encodes for, Kv10.1, to be overactive in neurons of the brain. Many individuals are not diagnosed until after they begin to have seizures or miss developmental milestones, and diagnosis requires genetic sequencing. No cure for KCNH1-related disorders is currently available, and treatment focuses on alleviating symptoms. Some individuals achieve seizure control using existing anti-seizure medications.
One phenotype is called Temple–Baraitser syndrome (TBS), a very rare autosomal dominant genetic disorder, characterised by intellectual disability, epilepsy, small or absent nail of the thumbs and great toes, and distinct craniofacial features. Other phenotypes are called Zimmermann–Laband syndrome type 1.
Signs and symptoms
A wide spectrum of symptoms and severity appears in KCNH1-related disorders.
The public source identifies “KCNH1-related disorders” as group of genetic disorders. This brief keeps that definition visible, then builds a research path around KCNH1-related, disorders and group.
Why this record matters
A short description can identify a subject without explaining its stakes. For “KCNH1-related disorders”, the useful work is to connect “group of genetic disorders” to the records capable of establishing context and consequence.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Mar 13, 2026. The linked authority identifier is Q136798895. None of the 0 selected statements returned an explicit reference.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “KCNH1-related disorders”, its source revision and the description used here.
- Expand the search: follow KCNH1-related disorders primary sources, KCNH1-related disorders archive and KCNH1-related research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “KCNH1-related disorders”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “KCNH1-related disorders” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.